Below you will find the articles on economics, investing, and finance that we found most interesting for the week.
NB: ($) denotes subscription site.
The uranium market shows signs of life.
The Financial Times investigates the drug company pricing playbook.
President Trump says companies should report every six months, instead of quarterly. We haven’t said it too often lately, but this is an idea that makes sense.
Cliff Asness makes a well-argued case against “buyback derangement syndrome.” Buybacks just don’t matter as much as many people think they do.
The Washington Post has an interesting anecdotal look at what immuno-oncology treatment can look like for a patient, in this case, Barbara Lipska, author of “The Neuroscientist Who Lost Her Mind.”